Torrent Pharmaceuticals Limited has informed the Exchange regarding 'Disclosure under Regulation 30 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015'.
TORNTPHARM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Torrent Pharmaceuticals has received approval from the Competition Commission of South Africa on 22nd September 2025 for its previously announced acquisition of a controlling stake in J. B. Chemicals & Pharmaceuticals from KKR. This is a further regulatory update following the original media release dated 29th June 2025 and stock exchange intimation dated 3rd July 2025. The South African approval is one of the cross-border regulatory clearances required to close the deal. Torrent has reaffirmed its commitment to maintaining fair and consistent relationships with all customers post-acquisition.
Positive incremental development for the deal's closure; one more regulatory hurdle cleared, bringing the acquisition closer to completion. No immediate financial impact, but progress reduces deal-related uncertainty for shareholders.